经外周中长改良静脉导管在颅脑肿瘤患者静脉治疗中的应用

Application Effects of Improved Midline Catheter to Intravenous Therapy of Patients with Brain Tumor

目的探讨经外周中长改良静脉导管在颅脑肿瘤患者静脉治疗中的应用效果。方法选取我院肿瘤科及神经外科2019年6月至2021年7月收治的74例颅脑肿瘤患者为研究对象。根据静脉治疗工具选择的不同分为对照组和观察组。对照组:以外周留置针行静脉治疗的患者42例,观察组:以外周中长改良静脉导管行静脉治疗的患者32例。比较两组病人的一般资料、甘露醇输注时间合格率、静脉穿刺频率、技术服务满意度及静脉治疗的并发症发生率。结果两组患者一般数据没有统计学差异(P>0.05)。对照组静脉穿刺次数、静脉治疗发生并发症频率超过了观察组,差异具有统计学意义(P<0.05);对照组技术服务满意度、甘露醇输注时间合格率低于观察组,差异具有统计学意义(P<0.05)。结论经外周中长改良静脉导管在颅脑肿瘤患者静脉治疗中具有良好的应用价值,值得推广。

Objectives To explore the application effects of improved midline catheter in intravenous therapy of patients with brain tumor.Methods 74 patients with brain tumor were studied.They were admitted to Neurosurgery and Oncology Department of our hospital from June 2019 to July 2021.According to the different selection of intravenous therapy tools,they were divided into control group and observation group.42 patients who were received intravenous therapy through peripherally inserted indwelling needle were the control group.The other 32 patients who were given intravenous therapy through improved midline catheter were the observation group.Comparisons were made between the two groups,including the general information,the pass rate of mannitol infusion time,the frequency of intravenous puncture,the technical service satisfaction and the incidence of complications during intravenous therapy.Results There is no statistical difference in the general data of the two groups(P>0.05).Compared with the observation group,the frequency of intravenous puncture and the incidence of complications during intravenous therapy in the control group were higher,and the difference was statistically significant(P<0.05).The technical service satisfaction and the pass rate of mannitol infusion time of the control group were lower than that of the experiment group,and the difference was statistically significant(P<0.05).Conclusion The improved midline catheter has a good application value in the venous treatment of patients with brain tumor and is worth promoting.